Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Supply increase to help meet growing global demand
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Sales reflect continued strong growth in oncology and vaccines
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
Subscribe To Our Newsletter & Stay Updated
